Possinger K, Hartenstein R, Misera C, Ehrhart H
Blut. 1981 Aug;43(2):105-7. doi: 10.1007/BF00320469.
In 36 Walker-ascites-carcinosarcoma bearing rats the reduction of 3H-TdR-incorporation into tumor cells after cytotoxic treatment as an potential prognostic factor for efficacy of chemotherapy was tested. Twelve rats each were i.p. treated with 1 mg/kg bw. DDP resp. 0.8 mg/kg bw. adriamycin. Twelve rats were injected with 0.2 mg phs. NaCl and served as control. Survival of rats served as criterion of therapeutic efficacy. There was a significant correlation between reduction of 3H-TdR-uptake in tumor cells after cytotoxic therapy and survival.
在36只患有沃克腹水癌肉瘤的大鼠中,测试了细胞毒性治疗后肿瘤细胞中3H-胸腺嘧啶核苷(3H-TdR)掺入量的降低作为化疗疗效潜在预后因素的情况。每组12只大鼠分别经腹腔注射1 mg/kg体重的顺铂(DDP)或0.8 mg/kg体重的阿霉素。12只大鼠注射0.2 mg的生理盐水作为对照。大鼠的存活情况作为治疗效果的标准。细胞毒性治疗后肿瘤细胞中3H-TdR摄取量的降低与存活率之间存在显著相关性。